In a feat of trickery, Dartmouth Medical School immunologists have devised a Trojan horse to help overcome ovarian cancer, unleashing a surprise killer in the surroundings of a hardtotreat tumor.
Using nanoparticlesultra small bits the team has reprogrammed a protective cell that ovarian cancers have corrupted to feed their growth, turning the cells back from tumor [...]

Critical Outcome Technologies Inc. (TSX VENTURECOT), announced positive results today from combination agent animal experiments carried out at a prominent American cancer research facility. The results provide strong supportive evidence for the continued evaluation of COTI2 in combination with conventional single agent therapy for the treatment of ovarian cancer
Tumor growth inhibition was significantly [...]